The Piramal Pharma Solutions Client Advisory Board (CAB) assists with the strategic planning, long-term performance and future direction of the company. By achieving a better understanding of how our clients work with us and what they expect of us, we will be better equipped to provide value to them in all phases of our business.
The objectives of the CAB are: to facilitate open discussion between PPS and its clients; gain early identification of shifting needs; identify business drivers and best practices; evaluate current and potential new offerings; explore partnership, pricing and risk-sharing models; ensure that we meet current expectations and future needs; gather market intelligence; and support and enhance the Patient Centricity ethos at both the sponsor and CDMO levels.